6533b7cffe1ef96bd12583f2

RESEARCH PRODUCT

Ruthenium-Containing Block Copolymer Assemblies: Red-Light-Responsive Metallopolymers with Tunable Nanostructures for Enhanced Cellular Uptake and Anticancer Phototherapy.

Volker MailänderVolker MailänderMaria ParowatkinWerner SteffenSi WuWen SunHans-jürgen Butt

subject

Materials scienceLightStereochemistryCell SurvivalPolymersBiomedical EngineeringPharmaceutical Sciencechemistry.chemical_element02 engineering and technology010402 general chemistry01 natural sciencesMicelleRutheniumPolyethylene GlycolsBiomaterialschemistry.chemical_compoundNeoplasmsSide chainCopolymerMoietyHumansProdrugsMicellesPhototherapy021001 nanoscience & nanotechnologyCombinatorial chemistry0104 chemical sciencesRutheniumNanostructuresMolecular WeightchemistrySelf-assemblyTerpyridine0210 nano-technologyEthylene glycolHydrophobic and Hydrophilic InteractionsHeLa Cells

description

The use of self-assembled nanostructures consisting of red-light-responsive Ru(II)-containing block copolymers (BCPs) for anticancer phototherapy is demonstrated. Three Ru-containing BCPs with different molecular weights are synthesized. Each BCP contains a hydrophilic poly(ethylene glycol) block and an Ru-containing block. In the Ru-containing block, more than half of the side chains are coordinated with [Ru(2,2':6',2''-terpyridine)(2,2'-biquinoline)](2+) , resulting in more than 40 wt% Ru complex in the BCPs. The Ru complex acts as both a red-light-cleavable moiety and a photoactivated prodrug. Depending on their molecular weights, the BCPs assemble into micelles, vesicles, and large compound micelles. All of the BCP assemblies are taken up by cancer cells. Red-light irradiation releases the Ru complex and generates singlet oxygen ((1) O2 ) in cancer cells. The released Ru complex and (1) O2 inhibit the growth of cancer cells. Among the three BCP assemblies, the BCP micelle exhibits the most efficient cellular uptake and best anticancer performance.

10.1002/adhm.201500827https://pubmed.ncbi.nlm.nih.gov/26680371